Medical Market Report

Global Central Vascular Access Devices Market By Type (Peripherally inserted central catheters (PICC), Tunneled catheters, Non tunneled catheters, and Implanted ports), By Application (Drug administration, Fluid and nutrition administration, Blood transfusion, and Diagnostics & testing), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 138285
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Central Vascular Access Devices Market is estimated to be valued US$ XX.X million in 2019. The report on Central Vascular Access Devices Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global central vascular access devices market is segmented on the basis of Type, Application, and geography.

    Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.

    Central Vascular Access Devices Market Scope:

    By type, the market is segmented into Peripherally inserted central catheters (PICC), Tunneled catheters, Non tunneled catheters, and Implanted ports. By Application, the market is divided into Drug administration, Fluid and nutrition administration, Blood transfusion, and Diagnostics & testing.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Becton, Dickinson and Company (U.S.), C. R. Bard, Inc. (U.S.), Smiths Medical, Inc. (U.K.), Teleflex Incorporated (U.S.), B.Braun Melsungen AG (Germany), NIPRO Medical Corporation (Japan), Edwards Lifesciences Corporation (U.S.), Terumo Corporation (Japan), Vygon Ltd. (U.K.), Ameco Medical (Egypt), AngioDynamics (U.S.), Romsons Scientific & Surgical Pvt. Ltd. (India), and PRODIMED (France).

    Key Market Segments

    Type

    Peripherally inserted central catheters (PICC)

    Tunneled catheters

    Non tunneled catheters

    Implanted ports

    Application

    Drug administration

    Fluid and nutrition administration

    Blood transfusion

    Diagnostics & testing

    Key Market Players included in the report:

    Becton

    Dickinson and Company (U.S.)

    C. R. Bard, Inc. (U.S.)

    Smiths Medical, Inc. (U.K.)

    Teleflex Incorporated (U.S.)

    B.Braun Melsungen AG (Germany)

    NIPRO Medical Corporation (Japan)

    Edwards Lifesciences Corporation (U.S.)

    Terumo Corporation (Japan)

    Vygon Ltd. (U.K.)

    Ameco Medical (Egypt)

    AngioDynamics (U.S.)

    Romsons Scientific & Surgical Pvt. Ltd. (India)

    PRODIMED (France)

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Central Vascular Access Devices Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Central Vascular Access Devices Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Central Vascular Access Devices Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Central Vascular Access Devices Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Central Vascular Access Devices Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Central Vascular Access Devices Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Central Vascular Access Devices sub-markets, depending on key regions (various vital states).
    To analyze Central Vascular Access Devices Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Central Vascular Access Devices Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Central Vascular Access Devices Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Central Vascular Access Devices Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope
    

    2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players
    

    3. Global Central Vascular Access Devices Market Overview
    

    3.1. Central Vascular Access Devices Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
    

      3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy
    

    4. Global Central Vascular Access Devices Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Central Vascular Access Devices Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Peripherally inserted central catheters (PICC)
    

      4.4. Tunneled catheters
    

      4.5. Non tunneled catheters
    

      4.6. Implanted ports
    

    5. Global Central Vascular Access Devices Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Central Vascular Access Devices Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Drug administration
    

      5.4. Fluid and nutrition administration
    

      5.5. Blood transfusion
    

      5.6. Diagnostics & testing
    

    6. Global Central Vascular Access Devices Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Central Vascular Access Devices Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Central Vascular Access Devices Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Central Vascular Access Devices Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Central Vascular Access Devices Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Central Vascular Access Devices Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    

    7. Global Central Vascular Access Devices Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Becton
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
    

      7.4. Dickinson and Company (U.S.)
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
    

      7.5. C. R. Bard, Inc. (U.S.)
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
    

      7.6. Smiths Medical, Inc. (U.K.)
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
    

      7.7. Teleflex Incorporated (U.S.)
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
    

      7.8. B.Braun Melsungen AG (Germany)
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
    

      7.9. NIPRO Medical Corporation (Japan)
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
    

      7.10. Edwards Lifesciences Corporation (U.S.)
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
    

      7.11. Terumo Corporation (Japan)
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
    

      7.12. Vygon Ltd. (U.K.)
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
    

      7.13. Ameco Medical (Egypt)
    

        7.13.1. Company Overview
    
    7.13.2. Financial Highlights
    
    7.13.3. Product Portfolio
    
    7.13.4. SWOT Analysis
    
    7.13.5. Key Strategies and Developments
    

      7.14. AngioDynamics (U.S.)
    

        7.14.1. Company Overview
    
    7.14.2. Financial Highlights
    
    7.14.3. Product Portfolio
    
    7.14.4. SWOT Analysis
    
    7.14.5. Key Strategies and Developments
    

      7.15. Romsons Scientific & Surgical Pvt. Ltd. (India)
    

        7.15.1. Company Overview
    
    7.15.2. Financial Highlights
    
    7.15.3. Product Portfolio
    
    7.15.4. SWOT Analysis
    
    7.15.5. Key Strategies and Developments
    

      7.16. PRODIMED (France)
    

        7.16.1. Company Overview
    
    7.16.2. Financial Highlights
    
    7.16.3. Product Portfolio
    
    7.16.4. SWOT Analysis
    
    7.16.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.